Tangen Biosciences, Inc. — Form D

Tangen Biosciences, Inc. of BRANFORD, CT, a company, filed a Form D exempt-offering notice with the SEC on 2019-03-22. The offering totals $11.1M, of which $6.7M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (23)

NameRoleLocation
Christopher McLeodDirectorBranford, CT
Daniel V WagnerDirectorWoodbridge, CT
Dan WagnerDirectorWashington, DC
John DavidsonDirectorGreenwood Village, CO
John DavidsonExecutive OfficerGreenwood Village, CO
Alan V LevinDirectorBranford, CT
Richard C Birkmeyer, PhDDirectorBranford, CT
Richard C Birkmeyer, PhDExecutive OfficerBranford, CT
Vance V KershnerDirectorBranford, CT
Christopher V McLeodDirectorBranford, CT
John V DavidsonDirectorBranford, CT
John V DavidsonExecutive OfficerBranford, CT
Christopher BenoitDirectorLowell, MA
Brian ChiricoExecutive OfficerBranford, CT
Richard Birkmeyer, PhDDirectorBranford, CT
Richard Birkmeyer, PhDExecutive OfficerBranford, CT
John NobileDirectorBranford, CT
John Richard NobileDirectorBranford, CT
John Richard NobileExecutive OfficerBranford, CT
John Richard NobilePromoterBranford, CT
John Richard DavidsonDirectorBranford, CT
John Richard DavidsonExecutive OfficerBranford, CT
John Richard DavidsonPromoterBranford, CT

Other filings by this issuer (4)

FiledFormOfferingSold
2023-06-06D$2.5M$465K
2020-07-01D$20.0M$11.2M
2016-11-02D$8.0M
2015-12-28D$3.0M$2.0M

More